Drug-eluting beads bronchial arterial chemoembolization/bronchial arterial infusion chemotherapy with and without PD-1 blockade for advanced non-small cell lung cancer: a comparative single-center cohort study

医学 内科学 肺癌 单中心 回顾性队列研究 化疗 吉西他滨 肿瘤科 队列 封锁 受体
作者
Sheng Xu,Yuanming Li,Zhixin Bie,Xiaoguang Li
出处
期刊:Quantitative imaging in medicine and surgery [AME Publishing Company]
卷期号:13 (9): 6241-6256 被引量:20
标识
DOI:10.21037/qims-23-287
摘要

Background: Drug-eluting beads bronchial arterial chemoembolization (DEB-BACE)/bronchial artery infusion chemotherapy (BAI) have been investigated as treatment options for advanced non-small cell lung cancer (NSCLC), especially for those patients who develop refractoriness to or are intolerant to systemic chemotherapy. This retrospective study aimed to compare the outcomes of DEB-BACE/BAI with and without programmed cell death protein 1 (PD-1) blockade for advanced NSCLC, and to investigate the effectiveness and safety of combination regimens. Methods: This retrospective cohort study included advanced NSCLC patients who were intolerant to or were resistant to systemic chemotherapy, radiotherapy, or molecular targeted therapy and underwent DEB-BACE/BAI between October 2016 and October 2021 in Beijing Hospital, National Center of Gerontology. A total of 84 advanced NSCLC patients (DEB-BACE/BAI + PD-1 blockade group: group A, n=27; DEB-BACE/BAI: group B, n=57) were enrolled finally. The embolic agent CalliSpheres (100-300, 300-500, or 500-700 µm) loaded with gemcitabine (800 mg) was administered during the DEB-BACE procedure. The adverse events (AEs) and outcomes were compared. Of these, the median progression-free survival (PFS) and overall survival (OS) were compared via Kaplan-Meier (KM) methods. Univariate and multivariate Cox regression analyses were used to investigate the predictors of PFS and OS. Results: 8.0 months, P<0.001) than group B. The predictors of PFS for DEB-BACE/BAI included tumor diameter (P=0.013), immunotherapy (P<0.001), and DEB-BACE/BAI cycles (P=0.012), whereas the predictors of OS included tumor diameter (P=0.021), extrapulmonary metastases (P=0.041), immunotherapy (P<0.001), and DEB-BACE/BAI cycles (P=0.020). The incidence rates of overall AEs in groups A and B were 40.7% (11/27) and 36.8% (21/57), respectively, and no significant difference was found (P=0.731). Group A had an incidence rate of 11.1% for grade 3 immunotherapy-related AEs (irAEs). There were no incidences of ectopic embolization or spinal artery injury. Conclusions: Compared with DEB-BACE/BAI, PD-1 blockade plus DEB-BACE/BAI could improve the prognosis for advanced NSCLC despite the associated risk of grade 3 irAEs. The combination regimens are promising and safe approaches for advanced NSCLC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
梵高的向日葵完成签到,获得积分10
1秒前
Ava的应助被宇智波小小怪采纳,获得10
1秒前
sagitar的应助被哈哈采纳,获得20
1秒前
俏皮夏菡发布了新的文献求助20
1秒前
123564举报苹果的求助涉嫌违规
2秒前
2秒前
坚强孤容发布了新的文献求助10
3秒前
3秒前
yang666完成签到,获得积分10
3秒前
5秒前
6秒前
7秒前
灰白发布了新的文献求助30
8秒前
9秒前
欣喜雨真完成签到,获得积分10
11秒前
xixi完成签到,获得积分10
12秒前
高瑛键完成签到,获得积分10
12秒前
聪明的行云完成签到 ,获得积分10
12秒前
cy发布了新的文献求助10
13秒前
Hello的应助被mooncake187采纳,获得10
13秒前
14秒前
14秒前
15秒前
NexusExplorer的应助被标致的秋荷采纳,获得10
16秒前
明理冷梅完成签到 ,获得积分10
16秒前
灰白完成签到,获得积分10
16秒前
追光完成签到,获得积分10
17秒前
一兰完成签到 ,获得积分10
17秒前
Dryad完成签到,获得积分10
18秒前
19秒前
霡霂发布了新的文献求助10
19秒前
渡花发布了新的文献求助30
20秒前
Shawn完成签到,获得积分10
20秒前
20秒前
冷傲路灯完成签到 ,获得积分10
22秒前
极HAO完成签到,获得积分10
22秒前
小情绪发布了新的文献求助10
23秒前
山外方有山完成签到,获得积分10
23秒前
阿王不理你完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186750
求助须知:如何正确求助?哪些是违规求助? 9575027
关于积分的说明 21839240
捐赠科研通 7784331
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611